¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"direct fluorescent antibody"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • direct association
    Á÷Á¢¿¬°ü¼º
  • direct bilirubin
    Á÷Á¢ºô¸®·çºó
  • direct Coombs test
    Á÷Á¢ÄñÁî°Ë»ç
  • direct coupling
    Á÷Á¢¿¬°á, Á÷Á¢°áÇÕ
  • direct cross matching
    Á÷Á¢±³Â÷½ÃÇè
  • direct current
    Á÷·ù
  • direct development
    Á÷Á¢¹ßÀ°
  • direct diplopia
    °°ÀºÂʺ¹½Ã, µ¿Ãøº¹½Ã
  • direct flap
    Á÷Á¢ÇÇÆÇ
  • direct inguinal hernia
    Á÷Á¢»ô±¼Å»Àå, Á÷Á¢¼­ÇýÅ»Àå
  • direct ophthalmoscope
    Á÷»ó°Ë¾È°æ, ¹Ù·Î´«º¸°³
  • direct pulp capping
    Á÷Á¢Ä¡¼öijÇιý
  • direct repeat
    µ¿Çâ¹Ýº¹
  • direct retainer
    Á÷Á¢À¯ÁöÀåÄ¡
  • direct smear
    Á÷Á¢Æì¹Ù¸¥Ç¥º», Á÷Á¢µµ¸»Ç¥º»
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antigen-antibody reaction
    Ç׿øÇ×ü¹ÝÀÀ
  • antibody synthesis
    Ç×üÇÕ¼º
  • antibody titer
    Ç×ü°¡
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • direct coupling
    Á÷Á¢¿¬°á, Á÷Á¢°áÇÕ
  • direct current
    Á÷·ù
  • direct pulp capping
    Á÷Á¢Ä¡¼öijÇιý
  • direct
    Á÷Á¢-
  • direct development
    Á÷Á¢¹ßÀ°
  • direct flap
    Á÷Á¢ÇÇÆÇ
  • direct ophthalmoscope
    Á÷»ó°Ë¾È°æ, ¹Ù·Î´«º¸°³
  • direct repeat
    µ¿Çâ¹Ýº¹¼­¿­
  • direct retainer
    Á÷Á¢À¯ÁöÀåÄ¡
  • direct smear
    Á÷Á¢¹Ù¸¥Ç¥º»
  • direct transfusion
    (¢¡immediate transfusion) Áï½Ã¼öÇ÷, ¹Ù·Î¼öÇ÷
  • direct agglutination test
    Á÷Á¢ÀÀÁý°Ë»ç
  • direct antiglobulin test
    Á÷Á¢Çױ۷κҸ°°Ë»ç
  • direct conversion x-ray detector
    Á÷Á¢Àüȯ¿¢½º¼±°ËÃâ±â, Á÷Á¢º¯È¯¿¢½º¼±°ËÃâ±â
  • direct cross matching
    Á÷Á¢±³Â÷½ÃÇè
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Kell antigen and antibody
    ÄÌÇ׿øÇ×ü
  • Langmuir expression in drug-antibody binding
    ¾à¹°-Ç×ü °áÇÕ¿¡¼­ÀÇ ¶û¹¿¸£Ç¥Çö
  • Lewis antibody
    ·çÀ̽ºÇ×ü
  • Lutheran antibody
    ·çÅ×¶õÇ×ü
  • M2 antibody
    M2 Çü Ç×ü
  • P antibody
    P Ç×ü
  • Scl-70 antibody
    Scl-70 Ç×ü
  • acetylcholine receptor antibody
    ¾Æ¼¼Æ¿Äݸ°¼ö¿ëüÇ×ü
  • acetylcholine receptor antibody assay
    ¾Æ¼¼Æ¿Äݸ°¼ö¿ëü Ç×Ã¼ÃøÁ¤
  • adcc(antibody dependent cell mediated cytotoxicity)
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
  • albumin agglutinating antibody
    ¾ËºÎ¹ÎÀÀÁýÇ×ü(¡­ëêó¢ù÷ô÷).
  • anti-La antibody
    Ç×LaÇ×ü
  • anti-RNP antibody
    Ç× RNPÇ×ü
  • anti-Ro antibody
    Ç× RoÇ×ü
  • anti-SM antibody
    Ç×SMÇ×ü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • indirect fluorescent antibody technique
    °£Á¢Çü±¤Ç×ü¹ý
  • soluble antigen fluorescent antibody test
    °¡¿ëÇ׿øÇü±¤Ç×ü½ÃÇè
  • fluorescent dye
    Çü±¤»ö¼Ò.
  • fluorescent indicator
    Çü±¤Áö½Ã¾à.
  • fluorescent spot test
    Çü±¤Á¡(Àû)½ÃÇè
  • time-resolved fluorescent immunoassay
    ½Ã°£Â÷Çü±¤¸é¿ªÃøÁ¤(¹ý)
  • anterior pyramidal tract =direct p. t.
    1. ÀüÇÇÁúô¼ö·Î(îñù«òõô±âÐÖØ). 2. ÃßüÀü»è·Î(õÞô÷îñßãÖØ).
  • antiglobulin test, direct
    Á÷Á¢ Çױ۷κи° °Ë»ç
  • direct
    Á÷Á¢ÀÇ
  • direct
    Á÷Á¢ÀÇ.
  • direct (cell) division
    Á÷Á¢<¹«»ç>(¼¼Æ÷)ºÐ¿­.
  • direct action
    Á÷Á¢ÀÛ¿ë
  • direct agglutination test
    Á÷Á¢ÀÀÁý½ÃÇè
  • direct antagonist
    Á÷Á¢±æÇ×±Ù
  • direct antiglobulin test
    Á÷Á¢Çױ۷κҸ°½ÃÇè.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • antibody combining site
    Ç×ü°áÂø(ù÷ô÷Ì¿ó·)ÀÚ¸®
  • antibody dependent cellular cytotoxicity
    Ç×üÀÇÁ¸ÀÚ¸® ¼¼Æ÷¼º¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øààõá¬øàÔ¸àõ)
  • antibody diversity
    Ç×ü ´Ù¾ç¼º(ù÷ô÷ÒýåÆàõ)
  • antibody fixation
    Ç×ü °íÁ¤(ù÷ô÷ͳïÒ)
  • antibody formation
    Ç×ü Çü¼º(ù÷ô÷û¡à÷)
  • antibody heterogeneity
    Ç×ü ºÒ±ÕÀϼº(ù÷ô÷ÝÕгìéàõ)
  • antibody mediated hypersensitivity
    Ç×ü ¸Å°³ °ú¹ÎÁõ(ù÷ô÷ØÚ˿ΦÚÂñø)
  • antibody response
    Ç×ü ´ëÀÀ(ù÷ô÷Óßëë)
  • antibody specificity
    Ç×ü ƯÀ̼º(ù÷ô÷÷åì¶àõ)
  • antibody titer
    Ç×ü¿ª°¡(ù÷ô÷æ³Ê¤)
  • antibody valence
    Ç×ü°¡(ù÷ô÷ʤ)
  • antibody-excess zone
    Ç×ü°úÀ×±¸¿ª(ù÷ô÷Φí¥Ï¡æ´)
  • antigen-antibody complex
    Ç׿øÇ×ü º¹ÇÕü(ù÷ê«ù÷ô÷ ÜÜùêô÷)
  • antigen-antibody lattice
    Ç׿øÇ×ü °ÝÀÚ(ù÷ê«ù÷ô÷ Ì«í­)
  • antigen-antibody reaction
    Ç׿øÇ×ü ¹ÝÀÀ(ù÷ê«ù÷ô÷Úãëë)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DFA direct fluorescent antibody; discriminant function analysis; dorsiflexion assistance
ACA abnormal coronary artery; acrodermatitis chronica atrophicans; acute cerebellar ataxia; adenocarcino...
DAT delayed-action tablet; dementia Alzheimer's type; dental aptitude test; diacetylthiamine; diet as to...
DC daily census; data communication; data conversion; decrease; deep compartment; Dental Corps; deoxych...
AMA against medical advice; alkaline membrane assay; American Management Association; American Medical A...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
FTA-Abs Fluorescent Treponemal Antibody Absorbed
FTA-ABS Fluorescent Treponemal Antibody Absorption
FANA Fluorescent anti-nuclear antibody
FAT Fluorescent antibody technique
IFA Immuno fluorescent Antibody
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • direct immunofluorescene
    Á÷Á¢ Çü±¤ Ç×ü¹ý
    ¼¼Æ÷³ª Á¶Á÷ ±âÁú¿¡ ´ëÇÑ Ç×ü ±× ÀÚü¸¦ Çü±¤ »ö¼Ò¿Í °áÇÕ½ÃÄÑ Á÷Á¢ »ç¿ëÇÏ´Â ¹æ¹ý.
  • direct laterocapsular approach
    Á÷Á¢ °üÀý³¶ Ãø¹æ¿¡¼­ Á¢±ÙÇÏ´Â ¹ý
  • direct metaplasia
    Á÷Á¢ È­»ý
  • direct method
    Á÷Á¢¹ý
    ȯÀÚÀÇ ±¸°­³»¿¡¼­ ¿Î½º Á¶°¢ÇÏ¿© ³³ ¿øÇüÀ» ¾ò¾î ¸Å¸ôÇϰí ÁÖÁ¶ÇÏ¿© Àη¹À̳ª Ä¡°ü º¸Ã¶¹°À» ¾ò´Â ¹æ¹ýÀÌ´Ù.
  • direct pulp capping
    Á÷Á¢ Ä¡¼ö º¹Á¶¼ú, Ä¡¼ö Á÷Á¢ º¹Á¶¹ý
  • direct reflex
    Á÷Á¢ ¹Ý»ç
    ÀÚ±ØÀÇ À§Ä¡¿Í °°Àº ÂÊ¿¡¼­ ÀϾ´Â ¼öÃà.
  • direct retainer
    Á÷Á¢ À¯Áö ÀåÄ¡
    ¼öº¹¹°À» Å»¶ô½ÃŰ·Á´Â ÈûÀ» ¸·´Â ±¹¼Ò ÀÇÄ¡ÀÇ ÇÑ ºÎºÐÀ¸·Î À̰ÍÀº Áö´ëÄ¡¿¡ ÀÖ´Â ÇÔ¹°ºÎÀdzª Ä¡°æºÎÂÊÀÇ ¾ð´õÄÆ³»¿¡ À§Ä¡µÊÀ¸·Î½á ±×¸®°í ¸¶Âû·Â¿¡ ÀÇÇØ¼­ ¾ò¾îÁø´Ù. Á¾·ù·Î´Â Ä¡°ü³»½Ä°ú Ä¡°ü¿Ü½Ä À¯Áö ÀåÄ¡ÀÇ 2°¡Áö°¡ ÀÖ´Ù.
  • direct sagittal CT imaging
    Á÷Á¢ ½Ã»ó¸é ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ »ó
  • direct technic
    Á÷Á¢¹ý
  • direct traumatic perforation
    Á÷´Þ ¿Ü»ó õ°ø, Á÷Á¢ ¿Ü»ó õ°ø
  • indirect-direct method inlay
    Á÷Á¢ °£Á¢¹ý Àη¹ÀÌ
    Á÷Á¢¹ý°ú °£Á¢¹ýÀ» º´¿ëÇÏ¿© ¸¸µç Àη¹ÀÌ.
  • agglutination antibody titer
    ÀÀÁý Ç×ü ¿ª°¡
  • albumin agglutinating antibody
    ¾ËºÎ¹Î ÀÀÁý Ç×ü
  • alloimmune antibody
    µ¿Á¾ ¸é¿ª Ç×ü
  • anti-antibody
    Ç×Ç×ü
    Ç׿ø°ú °áÇÕÇÑ IgG classÀÇ Ç×ü ºÐÀڿ͸¸ °áÇÕÇÒ ¼ö ÀÖ´Â Ç×üÀÌ¸ç ºñƯÀÌÀûÀÎ ÀÀÁý IgG¿Í´Â ¹ÝÀÀÇÏÁö ¾Ê´Â Á¡¿¡¼­ ÀÌ Ç×ü´Â Ç׿ø Ç×ü °áÇÕ¹°ÀÇ °ËÃâ¿¡ ÀÀ¿ëµÇ°í ÀÖ´Ù. »ç¶÷ÀÇ ÀÚ¿¬ Ç×üÀÇ ÀÏÁ¾ÀÌ¸ç ·ù¸¶ÅäÀ̵å ÀÎÀÚÀÇ Æ¯¼öÇüÀ¸·Î º¸´Â °æÇâµµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
fluorescent Having the ability to emit light of a certain wavelength when activated by light of another wavelength.
(09 Oct 1997)
fluorescent dyes Dyes that emit light when exposed to light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. They are used as markers in biochemistry and immunology.
(12 Dec 1998)
fluorescent in situ hybridization See FISH.
(12 Dec 1998)
fluorescent label A molecule which fluoresces and can be attached to a probe molecule that does not fluoresce.
(09 Oct 1997)
fluorescent microscope <instrument> A microscope equipped to examine material that fluoresces under ultraviolet (UV) light.
(12 Dec 1998)
fluorescent screen A screen coated with fluorescent crystals such as the calcium tungstate used in the fluoroscope.
(05 Mar 2000)
fluorescent stain <technique> A stain or staining procedure using a fluorescent dye or substance that will combine selectively with certain tissue components and that will then fluoresce upon irradiation with ultraviolet or violet-blue light.
(05 Mar 2000)
non-direct transmission <epidemiology> A mode of transmission that differs in some mysterious way from indirect transmission.
(05 Dec 1998)
direct 1. Straight, in a straight line.
2. Performed immediately and without the intervention of subsidiary means.
Origin: L. Directus
(18 Nov 1997)
direct acrylic restoration A direct resin restoration of autopolymerizing acrylic.
(05 Mar 2000)
direct agglutination A general term for techniques which use the agglutination (macroscopic clumping) of particulate reagents as an indicator of the presence of an antigen-antibody reaction. Examples (haemagglutination, latex agglutination and coagglutination) follow.
(05 Mar 2000)
direct B-cell Lymphocytes responding to a small range of antigens by antibody production without any requirement for T-cells. The antigens include flagellin and pokeweed mitogen.
(18 Nov 1997)
direct bilirubin Conjugated bilirubin = Direct bilirubin. Bilirubin that has been chemically attached to a glucuronide in the liver. The bilirubin that is excreted into the bile by the liver and stored in the gallbladder or transferred to the duodenum. Normal direct bilirubin is 0 to 0.3 mg/dl. Greater than normal values can be seen in bile duct obstruction, cirrhosis, Crigler-Najjar syndrome, Dubin-Johnson syndrome and hepatitis.
(27 Sep 1997)
direct bone impression An impression of denuded bone, used in the construction of subperiosteal denture implants.
(05 Mar 2000)
direct composite resin restoration A direct restoration made by inserting a plastic mix of auto or light-polymerised resins in a cavity prepared in a tooth.
Synonym: direct composite resin restoration.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • direct initiative
    (Á¤)Á÷Á¢ ¹ßÀDZÇ
  • direct method
    (¿Ü±¹¾îÀÇ)Á÷Á¢ ±³¼ö¹ý(¿Ü±¹¾î¸¸À¸·Î °¡¸£Ä¡¸ç ¹®¹ý ±³À°µµ ÇÏÁö ¾ÊÀ½)
  • direct narration
    Á÷Á¢ È­¹ý 
  • direct object
    (¹®¹ý)Á÷Á¢ ¸ñÀû¾î
  • direct proportion
    Á¤ºñ·Ê
  • direct ratio
    (¼ö)Á¤ºñ;Á¤ºñ·Ê
  • direct speech
    (¹®¹ý)=DIRECT NARRATION
  • direct tax
    Á÷Á¢¼¼
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á